[1]
Amani, B. et al. 2021. Lopinavir/Ritonavir for COVID-19: a Systematic Review and Meta-Analysis. Journal of Pharmacy & Pharmaceutical Sciences. 24, (May 2021), 246–257. DOI:https://doi.org/10.18433/jpps31668.